RNU7-66P

Across TCGA pan-cancer cohorts, RNU7-66P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU7-66P data layer.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RNU7-66P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-66P expression acts as an unfavorable survival marker.

UCEC, STAD, and KIRC are the cancer types where RNU7-66P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Tertile	All	0.124	0.839	<.001	90	view →
STAD	OS	Tertile	All	0.201	0.689	<.001	72	view →
KIRC	DFS	Tertile	All	0.198	0.796	.005	30	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU7-66P–UCEC (DFS)

Open the UCEC breakdown →